Professor

Richard Boyd

Melbourne, VIC
Chief Scientific Officer
Cartherics
Contact via phone

Expertise

Immunology / vaccinology
OVERVIEW OF EXPERTISE IN RELATION TO THE COVID-19 OUTBREAK AND IMPACT

Extensive experience in T and now NK cell biology. Recently his group at Cartherics have generated Chimeric Antigen Receptor (CAR) technology to arm T cells to specifically target and kill cancer cells. This has been adapted to developing off-the-shelf iNK cells from induced pluripotential stem cells (iPSC). These cells are very potent killers of cancer cells and are being tested for the ability to kill viral infected target cells. They could be used to rid SARS-CoV-2 infected cells, They are adding specificity to the iNK cells using CAR technology which can also be applied to targeting virus infected cells, They also have experience with anti-inflammatory mesenchymal stem/stromal cells (MSC). A logical COVID-19 therapy would be the combination of CAR-iNK cells to lyse SARS-CoV-2 infected cells and MSCs to inhibit cytokine storm.

If you would like to update your profle please get in touch.

COVID-19 Expert Database

The COVID-19 Expert Database has been created to provide a mechanism for governments, the business sector, the research sector, and other decision-makers to easily access the expertise they need to inform their decision making.


Australia’s ability to navigate this fast-changing environment and to recover from it needs inputs from a range of researchers and other experts. All fields of expertise including: science, technology, engineering, mathematics, health, humanities, arts, and social science are needed.


If you have expertise that can contribute to the national and global effort to tackle and recover from COVID-19 and its scientific, health, social, cultural and economic implications, please register here.

© 2020 Australian Academy of Science

Top